Ginsenoside Rb1 and Compound K Improve Insulin Signaling and Inhibit ER Stress-associated NLRP3 Inflammasome Activation in Adipose Tissue

Overview

Journal J Ginseng Res

Date 2016 Oct 18

PMID 27746687

Citations 34

Authors

Weijie Chen

Junlian Wang

Yong Luo

Tao Wang

Xiaochun Li

Aiyun Li

Jia Li

Kang Liu

Baolin Liu

Affiliations

Soon will be listed here.

Abstract

Background: This study was designed to investigate whether ginsenoside Rb1 (Rb1) and compound K (CK) ameliorated insulin resistance by suppressing endoplasmic reticulum (ER) stress-induced inflammation in adipose tissue.

Methods: To induce ER stress, epididymal adipose tissue from mice or differentiated 3T3 adipocytes were exposed to high glucose. The effects of Rb1 and CK on reactive oxygen species production, ER stress, TXNIP/NLRP3 inflammasome activation, inflammation, insulin signaling activation, and glucose uptake were detected by western blot, emzyme-linked immunosorbent assay, or fluorometry.

Results: Rb1 and CK suppressed ER stress by dephosphorylation of IRE1α and PERK, thereby reducing TXNIP-associated NLRP3 inflammasome activation in adipose tissue. As a result, Rb1 and CK inhibited IL-1β maturation and downstream inflammatory factor IL-6 secretion. Inflammatory molecules induced insulin resistance by upregulating phosphorylation of insulin receptor substrate-1 at serine residues and impairing insulin PI3K/Akt signaling, leading to decreased glucose uptake by adipocytes. Rb1 and CK reversed these changes by inhibiting ER stress-induced inflammation and ameliorating insulin resistance, thereby improving the insulin IRS-1/PI3K/Akt-signaling pathway in adipose tissue.

Conclusion: Rb1 and CK inhibited inflammation and improved insulin signaling in adipose tissue by suppressing ER stress-associated NLRP3 inflammation activation. These findings offered novel insight into the mechanism by which Rb1 and CK ameliorate insulin resistance in adipose tissue.

Citing Articles

A Review of the Therapeutic Potential of Ginseng and Its Bioactive Components in Nonalcoholic Fatty Liver Disease.

Hao L, Li S, Li C, Zhang Z, Hu X, Yan H Drug Des Devel Ther. 2025; 19():83-96.

PMID: 39803604 PMC: 11725245. DOI: 10.2147/DDDT.S500719.

Weiwei Decoction alleviates gastric intestinal metaplasia through the olfactomedin 4/nucleotide-binding oligomerization domain 1/caudal-type homeobox gene 2 signaling pathway.

Zhou D, Zhang W, Song S, Hong X, Yang W, Li J World J Gastrointest Oncol. 2024; 16(7):3211-3229.

PMID: 39072182 PMC: 11271767. DOI: 10.4251/wjgo.v16.i7.3211.

Ginsenosides for the treatment of insulin resistance and diabetes: Therapeutic perspectives and mechanistic insights.

Kim T J Ginseng Res. 2024; 48(3):276-285.

PMID: 38707641 PMC: 11068994. DOI: 10.1016/j.jgr.2024.03.002.

Hypolipidemic effect and molecular mechanism of ginsenosides: a review based on oxidative stress.

Jin W, Li C, Yang S, Song S, Hou W, Song Y Front Pharmacol. 2023; 14:1166898.

PMID: 37188264 PMC: 10175615. DOI: 10.3389/fphar.2023.1166898.

Ginsenoside Rc from Panax Ginseng Ameliorates Palmitate-Induced UB/OC-2 Cochlear Cell Injury.

Gill N, Dowker-Key P, Hubbard K, Voy B, Whelan J, Hedrick M Int J Mol Sci. 2023; 24(8).

PMID: 37108509 PMC: 10139021. DOI: 10.3390/ijms24087345.

References

Akao T, Kida H, Kanaoka M, Hattori M, KOBASHI K . Intestinal bacterial hydrolysis is required for the appearance of compound K in rat plasma after oral administration of ginsenoside Rb1 from Panax ginseng. J Pharm Pharmacol. 1998; 50(10):1155-60. DOI: 10.1111/j.2042-7158.1998.tb03327.x. View

Zhang K, Kaufman R . From endoplasmic-reticulum stress to the inflammatory response. Nature. 2008; 454(7203):455-62. PMC: 2727659. DOI: 10.1038/nature07203. View

Mohamed I, Hafez S, Fairaq A, Ergul A, Imig J, El-Remessy A . Thioredoxin-interacting protein is required for endothelial NLRP3 inflammasome activation and cell death in a rat model of high-fat diet. Diabetologia. 2013; 57(2):413-23. PMC: 3947289. DOI: 10.1007/s00125-013-3101-z. View

Gual P, Le Marchand-Brustel Y, Tanti J . Positive and negative regulation of insulin signaling through IRS-1 phosphorylation. Biochimie. 2005; 87(1):99-109. DOI: 10.1016/j.biochi.2004.10.019. View

Gao D, Madi M, Ding C, Fok M, Steele T, Ford C . Interleukin-1β mediates macrophage-induced impairment of insulin signaling in human primary adipocytes. Am J Physiol Endocrinol Metab. 2014; 307(3):E289-304. PMC: 4121578. DOI: 10.1152/ajpendo.00430.2013. View

Kim S, Na J, Song K, Choi D, Kim J, Kwon Y . Protective Effect of Ginsenoside Rb1 on Hydrogen Peroxide-induced Oxidative Stress in Rat Articular Chondrocytes. J Ginseng Res. 2013; 36(2):161-8. PMC: 3659580. DOI: 10.5142/jgr.2012.36.2.161. View

Haber C, Lam T, Yu Z, Gupta N, Goh T, Bogdanovic E . N-acetylcysteine and taurine prevent hyperglycemia-induced insulin resistance in vivo: possible role of oxidative stress. Am J Physiol Endocrinol Metab. 2003; 285(4):E744-53. DOI: 10.1152/ajpendo.00355.2002. View

Eizirik D, Cardozo A, Cnop M . The role for endoplasmic reticulum stress in diabetes mellitus. Endocr Rev. 2007; 29(1):42-61. DOI: 10.1210/er.2007-0015. View

Shang W, Yang Y, Zhou L, Jiang B, Jin H, Chen M . Ginsenoside Rb1 stimulates glucose uptake through insulin-like signaling pathway in 3T3-L1 adipocytes. J Endocrinol. 2008; 198(3):561-9. DOI: 10.1677/JOE-08-0104. View

10.

Oslowski C, Hara T, OSullivan-Murphy B, Kanekura K, Lu S, Hara M . Thioredoxin-interacting protein mediates ER stress-induced β cell death through initiation of the inflammasome. Cell Metab. 2012; 16(2):265-73. PMC: 3418541. DOI: 10.1016/j.cmet.2012.07.005. View

11.

Marciniak S, Ron D . Endoplasmic reticulum stress signaling in disease. Physiol Rev. 2006; 86(4):1133-49. DOI: 10.1152/physrev.00015.2006. View

12.

Zhou R, Tardivel A, Thorens B, Choi I, Tschopp J . Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat Immunol. 2009; 11(2):136-40. DOI: 10.1038/ni.1831. View

13.

Ringseis R, Eder K, Mooren F, Kruger K . Metabolic signals and innate immune activation in obesity and exercise. Exerc Immunol Rev. 2015; 21:58-68. View

14.

Joh E, Lee I, Jung I, Kim D . Ginsenoside Rb1 and its metabolite compound K inhibit IRAK-1 activation--the key step of inflammation. Biochem Pharmacol. 2011; 82(3):278-86. DOI: 10.1016/j.bcp.2011.05.003. View

15.

Schroder K, Tschopp J . The inflammasomes. Cell. 2010; 140(6):821-32. DOI: 10.1016/j.cell.2010.01.040. View

16.

Lambeth J, Neish A . Nox enzymes and new thinking on reactive oxygen: a double-edged sword revisited. Annu Rev Pathol. 2013; 9:119-45. DOI: 10.1146/annurev-pathol-012513-104651. View

17.

Cao S, Kaufman R . Endoplasmic reticulum stress and oxidative stress in cell fate decision and human disease. Antioxid Redox Signal. 2014; 21(3):396-413. PMC: 4076992. DOI: 10.1089/ars.2014.5851. View

18.

Aguirre V, Werner E, Giraud J, Lee Y, Shoelson S, White M . Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action. J Biol Chem. 2001; 277(2):1531-7. DOI: 10.1074/jbc.M101521200. View

19.

Hager S, Jochen A, Kalkhoff R . Insulin resistance in normal rats infused with glucose for 72 h. Am J Physiol. 1991; 260(3 Pt 1):E353-62. DOI: 10.1152/ajpendo.1991.260.3.E353. View

20.

Maedler K, Dharmadhikari G, Schumann D, Storling J . Interleukin-1 beta targeted therapy for type 2 diabetes. Expert Opin Biol Ther. 2009; 9(9):1177-88. DOI: 10.1517/14712590903136688. View